292 related articles for article (PubMed ID: 16791011)
1. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
[TBL] [Abstract][Full Text] [Related]
2. Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.
Lin YL; Mettling C; Portales P; Reynes J; Clot J; Corbeau P
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15590-5. PubMed ID: 12434015
[TBL] [Abstract][Full Text] [Related]
3. Galphai protein-dependant extracellular signal-regulated kinase-1/2 activation is required for HIV-1 reverse transcription.
Mettling C; Desmetz C; Fiser AL; Réant B; Corbeau P; Lin YL
AIDS; 2008 Aug; 22(13):1569-76. PubMed ID: 18670215
[TBL] [Abstract][Full Text] [Related]
4. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus-1 infection requires pertussis toxin sensitive G-protein-coupled signalling and mediates cAMP downregulation.
Guntermann C; Murphy BJ; Zheng R; Qureshi A; Eagles PA; Nye KE
Biochem Biophys Res Commun; 1999 Mar; 256(2):429-35. PubMed ID: 10079202
[TBL] [Abstract][Full Text] [Related]
6. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.
Alkhatib G; Locati M; Kennedy PE; Murphy PM; Berger EA
Virology; 1997 Aug; 234(2):340-8. PubMed ID: 9268166
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
9. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.
Paxton WA; Liu R; Kang S; Wu L; Gingeras TR; Landau NR; Mackay CR; Koup RA
Virology; 1998 Apr; 244(1):66-73. PubMed ID: 9581779
[TBL] [Abstract][Full Text] [Related]
10. Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.
Wade J; Sterjovski J; Gray L; Roche M; Chiavaroli L; Ellett A; Jakobsen MR; Cowley D; Pereira Cda F; Saksena N; Wang B; Purcell DF; Karlsson I; Fenyö EM; Churchill M; Gorry PR
Virology; 2010 Jan; 396(2):246-55. PubMed ID: 19913863
[TBL] [Abstract][Full Text] [Related]
11. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.
Reynes J; Portales P; Segondy M; Baillat V; André P; Réant B; Avinens O; Couderc G; Benkirane M; Clot J; Eliaou JF; Corbeau P
J Infect Dis; 2000 Mar; 181(3):927-32. PubMed ID: 10720514
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
14. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
[TBL] [Abstract][Full Text] [Related]
15. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.
Butticaz C; Ciuffi A; Muñoz M; Thomas J; Bridge A; Pebernard S; Iggo R; Meylan P; Telenti A
Antivir Ther; 2003 Oct; 8(5):373-7. PubMed ID: 14640383
[TBL] [Abstract][Full Text] [Related]
16. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
[TBL] [Abstract][Full Text] [Related]
17. Dichotomous effects of Plasmodium falciparum antigens on expression of human immunodeficiency virus (HIV) coreceptors and on infectability of CD4 cells by HIV.
Moriuchi M; Moriuchi H; Mon HM; Kanbara H
J Infect Dis; 2002 Oct; 186(8):1194-7. PubMed ID: 12355376
[TBL] [Abstract][Full Text] [Related]
18. R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.
Gondois-Rey F; Biancotto A; Fernandez MA; Bettendroffer L; Blazkova J; Trejbalova K; Pion M; Hirsch I
J Virol; 2006 Jan; 80(2):854-65. PubMed ID: 16378987
[TBL] [Abstract][Full Text] [Related]
19. [Human immunodeficiency virus (HIV) co-receptors expression in mononuclear leucocytes (ML) of HIV+ patients].
Belmonte L; de Elizalde de Bracco MM; Ruibal-Ares B
Medicina (B Aires); 2001; 61(5 Pt 2):670-2. PubMed ID: 12058586
[TBL] [Abstract][Full Text] [Related]
20. Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.
Guan Y; Abdelwahab S; Kamin-Lewis R; DeVico AL; Lewis GK
PLoS One; 2008; 3(10):e3481. PubMed ID: 18941536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
